FDA Drug Application (021433) for FLOVENT HFA by GLAXO GRP LTD

Back to FDA Applications sponsored by GLAXO GRP LTD

Application Number021433
Product Number001
FormAEROSOL, METERED;INHALATION
Dosage0.22MG/INH
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameFLOVENT HFA
Active IngredientFLUTICASONE PROPIONATE

Active IngredientCount
List of drugs with Active Ingredient FLUTICASONE PROPIONATE14


Back to FDA Applications sponsored by GLAXO GRP LTD